Preview

Современная ревматология

Расширенный поиск

Проблема боли в спине у больных остеопорозом

https://doi.org/10.14412/1996-7012-2012-748

Полный текст:

Литература

1. <div><p>Genant H.K., Wu C., van Kuijk et al. Vertebral fracture assessment using a semiquantitative technique. JBMR 1993; 8(9): 1137—48.</p><p>Haczynski J., Jakimiuk A. Vertebral fractures: a hidden problem of osteoporosis. Med Sci Moint 2001; 7(5): 1108—17.</p><p>Orstavik R., Haugeberg G., Kvien T.K. et al. Vertebral fractures in osteoporosis-silent fractures of clinical importance. Tidsskr Nor Laegeforen 2000; 120(24): 2891-4.</p><p>Francis R.M., Aspray T.J., Hide G. et al. Back pain in osteoporotic vertebral fractures. Osteopor Int 2008; 19: 895-903.</p><p>Clinical guidelines for the management of acute low back pain. London, Royal College of General Practitioners, 1996.</p><p>Насонова В.А. Ацеклофенак — безопасность и эффективность. РМЖ 2003; 11(5): 3—6.</p><p>Creamer J. A comparison of the pharmakokinetiks of single and repeated doses of aceclofenac in young and elderly volunteers. Brit J Clin Res 1992; 3: 99-107.</p><p>Lidburg P.S., Vojnovic J., Warner T.D. COX2/COX1 selectivity of aceclofenac in comparison with celecoxib and rofecoxob in the human whole blood assay / Fifth World Congress on the OARS, Barselona, Spain, 4—6 October, 2000; Suppl. B, Th053.</p><p>Saraf S. Aceclofenac: A Potent NonSteroidal Anti-Inflammatory Drug in Latest Reviews, 4(3).</p><p>Hinz B., Rau T., Augel D. et al. Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac. Clin Pharmacol Ther 2003; 74: 222-35.</p><p>Batlle-Gualda E., Roman Ivorra J., Martin-Mola E. et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial. Osteoarthr Cartil 2007; 15(8): 900-8.</p><p>Letzel H., Megard Y., Lamarca R. et al. The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea. Eur J Obstet Gynecol Reprod Biol 2006; 129(2): 162-8.</p><p>Presser Lima P., Fontanella V. Analgesic efficacy of aceclofenac after surgical extraction of impacted lower third molars. Int J Oral Maxillofac Surg 2006; 35(6): 518-21.</p><p>Schattenkirchner M., Milachowski K.A. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Clin Rheum 2003; 22(2): 127-35.</p><p>Lemmel E.M., Leeb B., De Bast J. et al. Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the management of inflammatory pain. Curr Med Res Opin 2002; 18(3): 146-53.</p><p>Huskinsson E.C., Irani M., Murray F. A large prospective open-label, multi-centre SAMM study, comparing the safety of aceclofenac with diclofenac in patients with rheumatic disease. Eur J Rheum Inflam 2000; 17: 1-7.</p><p>Laporte J., Ibanez L., Vidal X. et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 2004; 27: 411-20.</p><p>Lanas A., Garsia-Rodriguez L., Arroyo M. et al. Risk of upper gastrointestinal ulcer bleeding associated with selective COX-2 inhibitors, traditional non-steroidal nonaspirin NSAID, aspirin, and combinations. Gut published online 10 may 2006; doi: 10.1136/gut.2005.080754</p><p>Grau M., Guasch J., Montero J. et al. Pharmacology of the potent new nonsteroidal anti-inflammatory agent aceclofenac. Arzneimittelforschung 1991; 41(12): 1265-76.</p><p>Peris F., Bird H.A., Serni U. et al. Treatment compliance and safety of aceclofenac versus NSAIDs in patients with common arthritis disorders: a meta-analysis. Eur J Rheum Inflam 1996; 16: 37-45.</p><p>Helin-Salmivaara A., Virtanen A., Vesalainen R. et al. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J 2006; 27(14): 1657-63.</p><p>Blot L., Marcelis A., Devogelaer J.P. et al. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage. Br J Pharmacol 2000; 131(7): 1413-21.</p><p>Maneiro E., Lopez-Armada M.J., Fernandez-Sueiro J.L. et al. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes. J Rheum 2001; 28(12): 2692-9.</p></div><br />


Для цитирования:


Торопцова Н.В., Аникин С.Г. Проблема боли в спине у больных остеопорозом. Современная ревматология. 2012;6(3):56-60. https://doi.org/10.14412/1996-7012-2012-748

For citation:


Toroptsova N.V., Anikin S.G. Problem of back pain in patients with osteoporosis. Modern Rheumatology Journal. 2012;6(3):56-60. (In Russ.) https://doi.org/10.14412/1996-7012-2012-748

Просмотров: 768


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)